Uniplan Investment Counsel, Inc.
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1520710
MILWAUKEE, WI
Position in LGND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,022,935
+$13,175 QoQ
Shares Held
40,185
-5.1% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Uniplan Investment Counsel, Inc. holds $19,321,657 across 4 Biotechnology names. LGND ranks #1 (41.5% of the industry book) .
All Filings in LGND
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,022,935 | 40,185 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,009,760 | 42,364 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,471,056 | 42,176 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,156,496 | 62,953 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,232,790 | 68,792 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,302,808 | 68,155 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,315,179 | 53,104 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,180,728 | 49,617 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,011,793 | 41,201 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||